Back to Search Start Over

Dimeric Transmembrane Orientations of APP/C99 Regulate γ-Secretase Processing Line Impacting Signaling and Oligomerization.

Authors :
Perrin F
Papadopoulos N
Suelves N
Opsomer R
Vadukul DM
Vrancx C
Smith SO
Vertommen D
Kienlen-Campard P
Constantinescu SN
Source :
IScience [iScience] 2020 Dec 02; Vol. 23 (12), pp. 101887. Date of Electronic Publication: 2020 Dec 02 (Print Publication: 2020).
Publication Year :
2020

Abstract

Amyloid precursor protein (APP) cleavage by the β-secretase produces the C99 transmembrane (TM) protein, which contains three dimerization-inducing Gly-x-x-x-Gly motifs. We demonstrate that dimeric C99 TM orientations regulate the precise cleavage lines by γ-secretase. Of all possible dimeric orientations imposed by a coiled-coil to the C99 TM domain, the dimer containing the <superscript>33</superscript> Gly-x-x-x-Gly <superscript>37</superscript> motif in the interface promoted the Aβ <subscript>42</subscript> processing line and APP intracellular domain-dependent gene transcription, including the induction of BACE1 mRNA, enhancing amyloidogenic processing and signaling. Another orientation exhibiting the <superscript>25</superscript> Gly-x-x-x-Gly <superscript>29</superscript> motif in the interface favored processing to Aβ <subscript>43/40</subscript> . It induced significantly less gene transcription, while promoting formation of SDS-resistant "Aβ-like" oligomers, reminiscent of Aβ peptide oligomers. These required both Val24 of a pro-β motif and the <superscript>25</superscript> Gly-x-x-x-Gly <superscript>29</superscript> interface. Thus, crossing angles imposed by precise dimeric orientations control γ-secretase initial cleavage at Aβ <subscript>48</subscript> or Aβ <subscript>49,</subscript> linking the former to enhanced signaling and Aβ <subscript>42</subscript> production.<br />Competing Interests: S.N.C. is co-founder of Alsatech – Boston, MA and close family is owning stock in A.C. Immune Lausanne. The work of this manuscript is not linked to any current project at Alsatech or A.C. Immune, which are companies that work in the field of Alzheimer's disease.<br /> (© 2020 The Author(s).)

Details

Language :
English
ISSN :
2589-0042
Volume :
23
Issue :
12
Database :
MEDLINE
Journal :
IScience
Publication Type :
Academic Journal
Accession number :
33367225
Full Text :
https://doi.org/10.1016/j.isci.2020.101887